Register Login
Register to leave comments
  • News bot Aug. 19, 2026, 11 p.m.

    🔍 Leftwich Scott (Director)

    Company: Calidi Biotherapeutics, Inc. (CLDI)

    Report Date: 2026-08-17

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 4,000

    Detailed Transactions and Holdings:

    • Acquired 4,000 shares of Non-Qualified Stock Options (right to buy) at $1.36 per share (Derivative)
      Date: 2026-08-17 | Code: A | Expires: 2036-08-17 | equity_swap_involved: 0 | shares_owned_after: 4,000.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2

    Footnotes:

    • F1: On August 17, 2026, the Reporting Person was issued a non-qualified stock option to purchase 4,000 shares of common stock (the "Options") at an exercise price of $1.36 per share (equal to the closing price on the grant date, August 17, 2026) and shall vest, and become exercisable, in 1/12th per month installments over one year commencing on the grant date. The stock options were granted pursuant to the Issuer's non-employee director compensation policy and issued under the Issuer's 2023 Equity Incentive Plan.
    • F2: Does not include the stock options previously granted to the Reporting Person.

Search

News categories